13G/A filed by T. Rowe Price Investment Management, Inc.
T. Rowe Price Investment Management, Inc. reported 14,312,368 PCVX shares, 9.6% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-06 15:58:27 UTC.
- Accession
- 0001897612-26-000700
- Filer
- CIK 1897612
- Filed
- 2026-11-06
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- PCVX · VAXCYTE INC
- Shares
- 14,312,368
- Percent of class
- 9.6%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | IA | 13,699,251 | 0 | 14,312,368 | 0 | 14,312,368 | 9.6% |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13G/A 0001897612-26-000700 | this filing | 2026-11-06 | ||
| 13G/A 0001897612-26-000705 | amendment | 2026-11-06 |